The Evolving Role of HIV Counseling and Testing in Resource-limited Settings: HIV Prevention and Linkage to Expanding HIV Care Access.
The role of voluntary counseling and testing (VCT) of HIV in resource-limited settings has recently broadened from primarily that of a prevention intervention to its identification as the key entry point into expanding access to life-saving antiretroviral therapy, additional HIV--specific medical care, and other support services. To fulfill this expanded mandate, calls for routine counseling and testing in diverse health care settings, in addition to other innovative approaches to traditional VCT, are emerging. The efficacy and cost effectiveness of traditional facility-based VCT with respect to risk-behavior reduction of HIV have been demonstrated rigorously in resource-limited settings. Additional research is needed urgently to evaluate the feasibility, acceptability, and effectiveness of streamlined counseling and testing interventions that seek to reach as many individuals as possible to meet dual prevention and treatment goals.
Liechty
Cheryl A
CA
Positive Health Program, Department of Medicine-SFGH, University of California, San Francisco, Box 0874, SFGH Bldg 80, San Francisco, CA 94143, USA. liechtyc@cdcuganda.org.
AIDS Care. 1997 Feb;9(1):13-26
9155910
AIDS. 1992 Aug;6(8):869-74
1418784
Lancet. 2002 May 25;359(9320):1851-6
12044394
Lancet. 2003 May 3;361(9368):1569
12737909
Antimicrob Agents Chemother. 1999 Aug;43(8):1817-26
10428898
Lancet. 2000 Jul 8;356(9224):103-12
10963246
J Dev Behav Pediatr. 1994 Jun;15(3 Suppl):S54-60
8063921
AIDS Anal Afr. 1997 Dec;7(6):3
12348322
AIDS Educ Prev. 2001 Jun;13(3):279-89
11459363
Int J STD AIDS. 1998 Mar;9(3):134-8
9530897
Lancet. 2000 Jul 8;356(9224):113-21
10963247
N Engl J Med. 2000 Mar 30;342(13):921-9
10738050
Clin Infect Dis. 2000 Nov;31(5):1258-65
11073761
AIDS Care. 2000 Oct;12(5):625-42
11218548
MMWR Recomm Rep. 2001 Nov 9;50(RR-19):1-57; quiz CE1-19a1-CE6-19a1
11718472
N Engl J Med. 1997 Sep 18;337(12):801-8
9295239
AIDS. 2001 Mar 30;15(5):621-7
11317000
Int J Tuberc Lung Dis. 2003 Jan;7(1):65-71
12701837
Lancet. 1999 May 1;353(9163):1463-8
10232311
AIDS Care. 2001 Oct;13(5):605-15
11571007
AIDS. 1995;9 Suppl A:S251-7
8819593
East Afr Med J. 1996 Jan;73(1):20-6
8625856
Lancet. 2003 Nov 29;362(9398):1812-3
14661621
Curr Clin Top Infect Dis. 2002;22:214-51
12520656
AIDS. 2000 Sep;14 Suppl 2:S68-84
11061644
Lancet. 1995 Apr 8;345(8954):873-4
7707805
AIDS. 2000 Mar 10;14(4):427-34
10770546
AIDS Care. 1989;1(2):173-5
2488284
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 1;18(4):384-8
9704945
AIDS. 2001 May 25;15(8):1045-52
11399987
Lancet. 2003 Nov 29;362(9398):1847-9
14654325
Psychiatr Clin North Am. 1994 Mar;17(1):163-82
8190663
Am J Psychiatry. 1993 Nov;150(11):1679-86
8214177
AIDS Care. 1999 Feb;11(1):87-93
10434985
Lancet. 1999 May 1;353(9163):1469-75
10232312
J Acquir Immune Defic Syndr. 2001 Dec 15;28(5):463-70
11744836
Clin Infect Dis. 2002 May 15;34(10):1391-5
11981736